Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program.

RPEP-090682024Petrie, Mark C; Borlaug, Barry A; Butler, Javed; Davies, Melanie J; Kitzman, Dalane W; Shah, Sanjiv J; Verma, Subodh; Jensen, Thomas Jon; Einfeldt, Mette Nygaard; Liisberg, Karoline; Perna, Eduardo; Sharma, Kavita; Ezekowitz, Justin A; Fu, Michael; Melenovský, Vojtěch; Ito, Hiroshi; Lelonek, Małgorzata; Kosiborod, Mikhail N

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program.

Journal of the American College of Cardiology, 84(1), 27-40

View on PubMed ↗Publisher’s paper ↗

Citation

Petrie, Mark C; Borlaug, Barry A; Butler, Javed; Davies, Melanie J; Kitzman, Dalane W; Shah, Sanjiv J; Verma, Subodh; Jensen, Thomas Jon; Einfeldt, Mette Nygaard; Liisberg, Karoline; Perna, Eduardo; Sharma, Kavita; Ezekowitz, Justin A; Fu, Michael; Melenovský, Vojtěch; Ito, Hiroshi; Lelonek, Małgorzata; Kosiborod, Mikhail N. (2024). Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program.. Journal of the American College of Cardiology, 84(1), 27-40. https://doi.org/10.1016/j.jacc.2024.04.022